Back to Stakeholders
Government, Policy & AdvocacyRegulation & Enforcement
Government, Policy & AdvocacyRegulation & EnforcementClinical Guideline Development Groups
Government, Policy & AdvocacyPolicy Advocacy & Reform
Government, Policy & Advocacy
Government, Policy & AdvocacyPolicy Advocacy & ReformIndustry Associations & Lobby Groups
Care Delivery & Psychedelic Facilitation
Care Delivery & Psychedelic FacilitationPractitioner-Led Care Organizations
Care Delivery & Psychedelic FacilitationPractitioner-Led Care OrganizationsProfessional Associations & Medical Colleges
Care Delivery & Psychedelic FacilitationPractitioner-Led Care OrganizationsPsychiatry-Led Provider Organizations

American Psychiatric Association

United States
2 Trials

US professional psychiatric body that publishes position statements and guidance relevant to evidence standards and clinical policy considerations for psychedelic and empathogenic therapies.

Quick Facts

Type
Non-Profit
HQ
United States
Website
Visit

Collaborated Trials

2
RecruitingII

Psilocybin Therapy for Psychological Distress in Palliative Patients (PsyPal)

Start Date
Compounds
Psilocybin
CompletedI

Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling

Start Date
Compounds
Ketamine